Literature DB >> 24528171

Prevalence, clinical investigation, and management of gallbladder disease in Rett syndrome.

Michael Freilinger1, Michael Böhm, Ines Lanator, Klara Vergesslich-Rothschild, Wolf-Dietrich Huber, Alison Anderson, Kingsley Wong, Gordon Baikie, Madhur Ravikumara, Jenny Downs, Helen Leonard.   

Abstract

AIM: This study determined the prevalence of cholelithiasis and/or cholecystectomy in Rett syndrome, described gallbladder function in a clinical cohort, and identified recommendations for assessment and management of gallbladder disease.
METHOD: The incidence of cholelithiasis/cholecystectomy was estimated from data describing 270 and 681 individuals with a pathogenic MECP2 mutation in the Australian Rett Syndrome Database and the International Rett Syndrome Phenotype Database respectively. Gallbladder function in 25 females (mean age 16y 5mo, SD 20y 7mo, range 3y 5mo-47y 10mo) with Rett syndrome (RTT) was evaluated with clinical assessment and ultrasound of the gallbladder. The Delphi technique was used to develop assessment and treatment recommendations.
RESULTS: The incidence rate for cholelithiasis and/or cholecystectomy was 2.3 (95% confidence interval [CI] 1.1-4.2) and 1.8 (95% CI 1.0-3.0) per 1000 person-years in the Australian and International Databases respectively. The mean contractility index of the gallbladder for the clinical sample was 46.5% (SD 38.3%), smaller than for healthy individuals but similar to children with Down syndrome, despite no clinical symptoms. After excluding gastroesophageal reflux, gallbladder disease should be considered as a cause of abdominal pain in RTT and cholecystectomy recommended if symptomatic.
INTERPRETATION: Gallbladder disease is relatively common in RTT and should be considered in the differential diagnosis of abdominal pain in RTT.
© 2014 Mac Keith Press.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24528171     DOI: 10.1111/dmcn.12358

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  5 in total

1.  Consensus guidelines on managing Rett syndrome across the lifespan.

Authors:  Cary Fu; Dallas Armstrong; Eric Marsh; David Lieberman; Kathleen Motil; Rochelle Witt; Shannon Standridge; Paige Nues; Jane Lane; Tristen Dinkel; Monica Coenraads; Jana von Hehn; Mary Jones; Katie Hale; Bernhard Suter; Daniel Glaze; Jeffrey Neul; Alan Percy; Timothy Benke
Journal:  BMJ Paediatr Open       Date:  2020-09-13

Review 2.  Neurobiologically-based treatments in Rett syndrome: opportunities and challenges.

Authors:  Walter E Kaufmann; Jennifer L Stallworth; David B Everman; Steven A Skinner
Journal:  Expert Opin Orphan Drugs       Date:  2016-09-10       Impact factor: 0.694

Review 3.  Rett syndrome: a neurological disorder with metabolic components.

Authors:  Stephanie M Kyle; Neeti Vashi; Monica J Justice
Journal:  Open Biol       Date:  2018-02       Impact factor: 6.411

4.  Twenty years of surveillance in Rett syndrome: what does this tell us?

Authors:  Alison Anderson; Kingsley Wong; Peter Jacoby; Jenny Downs; Helen Leonard
Journal:  Orphanet J Rare Dis       Date:  2014-06-19       Impact factor: 4.123

5.  Phenotypes in adult patients with Rett syndrome: results of a 13-year experience and insights into healthcare transition.

Authors:  Angela Peron; Maria Paola Canevini; Filippo Ghelma; Rosangela Arancio; Miriam Nella Savini; Aglaia Vignoli
Journal:  J Med Genet       Date:  2020-10-26       Impact factor: 6.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.